Key Record Dates
ClinicalTrials.gov Identifier: | NCT02927769 |
---|---|
Brief Title: | A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment (CheckMate 744) |
First Submitted : | October 6, 2016 |
First Submitted that Met QC Criteria : | October 6, 2016 |
First Posted : | October 7, 2016 (Estimate) |
Last Update Submitted that Met QC Criteria : | June 8, 2020 |
Last Update Posted : | June 11, 2020 |